Pearland, TX – According to filings with the U.S. Securities and Exchange Commission, Adient Medical is raising $2,200,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mitchell Eggers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Adient Medical

Adient is the leader in the research, design and development of absorbable medical devices to prevent pulmonary embolism. In 2012, Adient embarked on a mission to prove that implantable medical devices could be safe and effective during their useful lifetime, then simply vanish without intervention. By introducing this innovative approach, patients could successfully avoid painful follow-up procedures and eliminate risks of future complications.

To learn more about Adient Medical, visit http://www.adientmedical.com/

Contact:
Mitchell Eggers, Chief Executive Officer
281-925-2727

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved